CME Group Inc. (NASDAQ:CME) Receives Consensus Rating of “Hold” from Brokerages

Shares of CME Group Inc. (NASDAQ:CME) have been given a consensus rating of “Hold” by the fifteen brokerages that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and five have issued a buy rating on the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $217.73.

A number of research firms recently commented on CME. TheStreet downgraded CME Group from a “b” rating to a “c+” rating in a research note on Wednesday, August 18th. Atlantic Securities raised CME Group from a “neutral” rating to an “overweight” rating and set a $230.00 target price for the company in a research note on Tuesday. Finally, Morgan Stanley boosted their target price on CME Group from $228.00 to $229.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 1st.

CME stock traded down $0.38 during midday trading on Tuesday, reaching $188.85. The company had a trading volume of 1,136,072 shares, compared to its average volume of 1,443,937. The company has a market capitalization of $67.82 billion, a price-to-earnings ratio of 35.30 and a beta of 0.43. The stock has a 50 day moving average price of $204.38 and a 200-day moving average price of $208.14. CME Group has a 1-year low of $146.89 and a 1-year high of $221.82. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 28th. The financial services provider reported $1.64 EPS for the quarter, beating the Zacks’ consensus estimate of $1.59 by $0.05. The business had revenue of $1.18 billion during the quarter, compared to the consensus estimate of $1.17 billion. CME Group had a return on equity of 8.33% and a net margin of 41.64%. As a group, research analysts anticipate that CME Group will post 6.65 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 27th. Stockholders of record on Friday, September 10th will be paid a $0.90 dividend. This represents a $3.60 annualized dividend and a dividend yield of 1.91%. The ex-dividend date of this dividend is Thursday, September 9th. CME Group’s dividend payout ratio is currently 53.57%.

In other news, insider Sean Tully sold 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 24th. The stock was sold at an average price of $200.20, for a total value of $1,001,000.00. Following the completion of the transaction, the insider now owns 23,479 shares of the company’s stock, valued at $4,700,495.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Martin J. Gepsman sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, August 23rd. The shares were sold at an average price of $201.37, for a total value of $201,370.00. The disclosure for this sale can be found here. Insiders sold 9,000 shares of company stock valued at $1,786,150 in the last ninety days. 0.30% of the stock is currently owned by insiders.

A number of hedge funds have recently made changes to their positions in the stock. Certified Advisory Corp bought a new position in shares of CME Group during the 1st quarter worth approximately $27,000. Solstein Capital LLC bought a new position in shares of CME Group during the 1st quarter worth approximately $28,000. RE Advisers Corp bought a new position in shares of CME Group during the 2nd quarter worth approximately $38,000. Capital Analysts LLC boosted its holdings in shares of CME Group by 370.0% during the 1st quarter. Capital Analysts LLC now owns 188 shares of the financial services provider’s stock worth $38,000 after buying an additional 148 shares in the last quarter. Finally, Glassman Wealth Services boosted its holdings in shares of CME Group by 54.0% during the 2nd quarter. Glassman Wealth Services now owns 191 shares of the financial services provider’s stock worth $41,000 after buying an additional 67 shares in the last quarter. Institutional investors and hedge funds own 86.19% of the company’s stock.

About CME Group

CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.

Further Reading: How to Use the MarketBeat Retirement Calculator

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.